Man Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-110,568
| Closed | -$1.7M | – | 2134 |
|
|
2025
Q1 | $1.7M | Buy |
110,568
+67,266
| +155% | +$1.03M | ﹤0.01% | 1239 |
|
|
2024
Q4 | $954K | Buy |
43,302
+28,457
| +192% | +$627K | ﹤0.01% | 1350 |
|
|
2024
Q3 | $268K | Sell |
14,845
-17,344
| -54% | -$313K | ﹤0.01% | 1654 |
|
|
2024
Q2 | $523K | Buy |
+32,189
| New | +$523K | ﹤0.01% | 1539 |
|
|
2023
Q3 | – | Sell |
-1,200,400
| Closed | -$9.04M | – | 2079 |
|
|
2023
Q2 | $9.04M | Buy |
+1,200,400
| New | +$9.04M | 0.03% | 649 |
|
|
2022
Q3 | – | Hold |
0
| – | -$289K | – | 2175 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1697 |
|
|
2021
Q2 | – | Sell |
-18,500
| Closed | -$213K | – | 2015 |
|
|
2021
Q1 | $213K | Buy |
+18,500
| New | +$213K | ﹤0.01% | 1738 |
|
|
2018
Q4 | – | Sell |
-4,300
| Closed | -$93K | – | 2095 |
|
|
2018
Q3 | $93K | Sell |
4,300
-14,428
| -77% | -$312K | ﹤0.01% | 2037 |
|
|
2018
Q2 | $455K | Buy |
+18,728
| New | +$455K | ﹤0.01% | 1819 |
|